Expanded safety analysis of pevonedistat, a first-in-class NEDD8-activating enzyme inhibitor, in patients with acute myeloid leukemia and myelodysplastic syndromes

R. T. Swords, J. Watts, H. P. Erba, J. K. Altman, M. Maris, Faiz - Anwer, Z. Hua, H. Stein, H. Faessel, F. Sedarati, B. J. Dezube, F. J. Giles, B. C. Medeiros, D. J. DeAngelo

Research output: Contribution to journalLetter

12 Scopus citations
Original languageEnglish (US)
Article numbere520
JournalBlood Cancer Journal
Volume7
Issue number2
DOIs
Publication statusPublished - Feb 3 2017

ASJC Scopus subject areas

  • Hematology
  • Oncology

Cite this